Ridgetech Inc. (RDGT): Financial results for FY2026
Ridgetech Inc. (RDGT) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Ridgetech, Inc. Reports Fiscal Year 2026 Financial Results HANGZHOU, China, July 31, 2026 /PRNewswire/ -- Ridgetech, Inc. (Nasdaq: RDGT) (“Ridgetech” or the “Company”), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced
How this was made
The 30-second read
Why it matters
The earnings release provides the first public view of post‑acquisition performance, showing mixed results.
Market read
RDGT's FY2026 results signal operational transition risks and opportunities for China pharma distributors.
What to watch
Improved cash balance and expanded digital footprint could offset short‑term earnings weakness.
Background
Ridgetech transitioned to a wholesale‑focused model, acquiring Allright and divesting retail stores.
Ticker impact
FY2026 earnings show 10.2% revenue growth to $132.2M but a net loss of $1.25M versus prior year profit.
Potential short-term downside pressure with limited upside unless guidance improves.
Loss reversal and modest revenue growth suggest weak earnings momentum; investors may sell.
Market effects
Highlights shift toward online wholesale in Chinese pharma distribution, offline decline.
May influence sentiment on China healthcare logistics and related peers.
Limited global impact; primarily relevant to China‑focused investors.
Counterpoint
Loss could be temporary as online platform scales; revenue growth may support a rebound.
Key entities
- CompanyRidgetech Inc.
Nasdaq‑listed Chinese wholesale distributor of pharmaceutical products.
- SubsidiaryAllright (Hangzhou) Internet Technology Co. Ltd
Online wholesale platform acquired by Ridgetech.